Prospective Testing for Loss or Over-Expression of p53 Identifies Barrett's Esophagus Patients at Increased Risk of Subsequent High Grade Dysplasia or Adenocarcinoma

被引:0
|
作者
Geisler, Daniel [1 ]
Tokuyama, Minami [2 ]
McGrath, Kevin [3 ]
Pai, Reetesh [4 ]
Davison, Jon [3 ]
机构
[1] UPMC, Pittsburgh, PA USA
[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[3] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
[4] UPMC Presbyterian Hosp, Pittsburgh, PA USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
674
引用
收藏
页码:665 / 666
页数:2
相关论文
共 50 条
  • [41] Detection of TP53 and Other Somatic Mutations in Barrett's Esophagus that Later Progresses to High Grade Dysplasia or Adenocarcinoma
    Stachler, Matthew
    Camarda, Nicholas D.
    Deitrick, Christopher
    Agoston, Agoston
    Odze, Robert
    Hornick, Jason L.
    Nag, Anwesha
    Thorner, Aaron R.
    Ducar, Matthew D.
    Carter, Scott L.
    Bass, Adam J.
    Davison, Jon
    MODERN PATHOLOGY, 2018, 31 : 303 - 303
  • [42] Detection of TP53 and Other Somatic Mutations in Barrett's Esophagus that Later Progresses to High Grade Dysplasia or Adenocarcinoma
    Stachler, Matthew
    Camarda, Nicholas D.
    Deitrick, Christopher
    Agoston, Agoston
    Odze, Robert
    Hornick, Jason L.
    Nag, Anwesha
    Thorner, Aaron R.
    Ducar, Matthew D.
    Carter, Scott L.
    Bass, Adam J.
    Davison, Jon
    LABORATORY INVESTIGATION, 2018, 98 : 303 - 303
  • [43] Long term results and risk factor analysis for recurrence in 349 patients with high grade dysplasia and mucosal adenocarcinoma in Barrett's esophagus
    Pech, Oliver
    Behrens, Angelika
    Nachbar, Lars
    May, Andrea
    Gossner, Liebwin
    Rabenstein, Thomas
    Manner, Hendrik
    GuNter, Erwin
    Vieth, Michael
    Stolte, Manfred
    Ell, Christian
    GASTROINTESTINAL ENDOSCOPY, 2007, 65 (05) : AB99 - AB99
  • [44] P53 and Racemase Immunohistochemistry in the Evaluation of Glandular Atypia Versus Low Grade Dysplasia/Indefinite for Dysplasia in a Large Cohort of Patients with Barrett Esophagus
    Petras, R.
    Jeung, J.
    Ly, T.
    Katzin, W.
    MODERN PATHOLOGY, 2013, 26 : 172A - 172A
  • [45] P53 and Racemase Immunohistochemistry in the Evaluation of Glandular Atypia Versus Low Grade Dysplasia/Indefinite for Dysplasia in a Large Cohort of Patients with Barrett Esophagus
    Petras, R.
    Jeung, J.
    Ly, T.
    Katzin, W.
    LABORATORY INVESTIGATION, 2013, 93 : 172A - 172A
  • [46] Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagus
    Kastelein, Florine
    Biermann, Katharina
    Steyerberg, Ewout W.
    Verheij, Joanne
    Kalisvaart, Marit
    Looijenga, Leendert H. J.
    Stoop, Hans A.
    Walter, Laurens
    Kuipers, Ernst J.
    Spaander, Manon C. W.
    Bruno, Marco J.
    GUT, 2013, 62 (12) : 1676 - 1683
  • [47] RISK FACTORS FOR PROGRESSION OF BARRETT'S ESOPHAGUS TO HIGH GRADE DYSPLASIA AND ESOPHAGEAL ADENOCARCINOMA: A LARGE RETROSPECTIVE COHORT STUDY
    Kambhampati, Swetha
    Luber, Brandon
    Wang, Hao
    Meltzer, Stephen J.
    GASTROENTEROLOGY, 2017, 152 (05) : S455 - S455
  • [48] VETERANS WITH CONFIRMED PERSISTENT BARRETT'S-ASSOCIATED LOW-GRADE DYSPLASIA ARE AT INCREASED RISK OF PROGRESSION TO HIGH GRADE DYSPLASIA AND ADENOCARCINOMA
    Song, Kevin
    Henn, Andrew J.
    Gravely, Amy
    Mesa, Hector
    Shaukat, Aasma
    Hanson, Brian J.
    GASTROINTESTINAL ENDOSCOPY, 2018, 87 (06) : AB86 - AB86
  • [49] Increased p53 Expression in the Malignant Transformation of Barrett's Esophagus is Accompanied by an Upward Shift of the Proliferative Compartment
    Hritz, Istvan
    Gyorffy, Hajnalka
    Molnar, Bela
    Lakatos, Gabor
    Sipos, Ferenc
    Pregun, Istvan
    Juhasz, Mark
    Pronai, Laszlo
    Schaff, Zsuzsa
    Tulassay, Zsolt
    Herszenyi, Laszlo
    PATHOLOGY & ONCOLOGY RESEARCH, 2009, 15 (02) : 183 - 192
  • [50] p53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus
    Schneider, PM
    Stoeltzing, O
    Roth, JA
    Hoelscher, AH
    Wegerer, S
    Mizumoto, S
    Becker, K
    Dittler, HJ
    Fink, U
    Siewert, JR
    CLINICAL CANCER RESEARCH, 2000, 6 (08) : 3153 - 3158